Endocannabinoid System Research: Cannabis for Autism Spectrum Disorder
Cannabis derivatives autism spectrum disorder research shows promising early signals for improving core symptoms and behavioral challenges. Current clinical trials reveal potential benefits but remain limited in size and scope. More research is needed to…
Cannabinoid Clinical Trials: Full-Spectrum Cannabis for Back Pain
This phase 3 trial evaluated the full-spectrum cannabis extract for chronic low back pain in 820 adults. The study showed pain reduction and sustained benefits over 12 months. Full-spectrum cannabis extract offers a promising option for patients with…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trials
Topical cannabis balms for AIMSS were tested in a randomized trial for breast cancer patients experiencing joint pain from aromatase inhibitor therapy. The study assessed feasibility and safety of cannabinoid topical treatments. Results provide early…
Review of Cannabis Derivatives in Autism Clinical Research
Cannabis derivatives autism clinical research shows preliminary benefits for symptoms like irritability and sleep difficulties. The evidence remains limited and requires cautious interpretation. Patients should consult clinicians before considering…
Endocannabinoid System Research: CBD & Cortical Excitability
In a controlled crossover trial, cannabidiol lacks direct effect on cortical excitability compared to placebo. This suggests CBD’s anti-seizure benefits depend on interactions with medications like clobazam. Clinicians should consider this when…
Endocannabinoid System Research: Cannabis for Endometriosis
Many people with endometriosis use cannabis for symptom relief, but clinical evidence is limited. This medicinal cannabis endometriosis trial evaluated safety and feasibility of inhaled THC and oral CBD oil. The study highlights challenges in conducting…
Cannabis Derivatives for Autism: Clinical Evidence & Research
Several randomized clinical trials have examined cannabis derivatives autism spectrum disorder symptoms. Findings suggest potential benefits for behavioral challenges and social functioning. The evidence base remains limited, so no definitive clinical…
Cannabinoids for Chronic Pain: Evidence and Clinical Insights
Cannabinoid efficacy chronic pain clinical evidence shows modest but consistent pain reduction in controlled trials. Clinical outcomes vary by product formulation and patient factors. This evidence supports cautious, individualized use in pain management.
Cannabinoids for Children: Clinical Evidence Reviewed
Current cannabinoids pediatric safety evidence spans 276 studies covering plant-derived and pharmaceutical formulations for children under 18. This clinical review synthesizes safety and reported benefits from interventional trials and observational…
VER-01 Cannabis Extract: Phase 3 Trial for Chronic Back Pain
The VER-01 cannabis extract clinical trial evaluated 820 adults with chronic low back pain in a rigorous phase 3 study. Results demonstrated significant pain reduction and a favorable safety profile. This trial adds important clinical evidence for…